Patient Benefit From the New Modular Shoulder Prosthesis PROMOS

NCT00925496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2020-04-06

No results posted yet for this study

Summary

Overall study design:

This study is a prospective, non-randomized, multicenter postmarket clinical follow-up study with two study arms using the two shoulder prosthesis PROMOS™ STANDARD (group A) and PROMOS REVERSE™ (group B). The study will collect efficacy and safety data over 10 years.

Conditions

  • Primary or Secondary Omarthrosis of the Shoulder Joint

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics AG

    lead INDUSTRY

Principal Investigators

  • Hans-Kaspar Schwyzer, Dr. med. · Schulthess Klinik

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00925496 on ClinicalTrials.gov